This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
|Name of User Fee||Fee Type||Fee-setting Authority||Reason for Planned Introduction of or Amendment to Fee||Effective Date of Planned Change||Consultation and Review Process Planned|
|Authority to Sell Drugs Fees - AMENDED||Regulatory Service (R)||Financial Administration Act (FAA)||
Fees are being amended because:
||2009-10||The User Fees proposals have gone through two rounds of consultations and the review by Independent Advisory Panels. Parliamentary Review of the Fee Proposals and Canada Gazette publication of proposed fees are planned in 2009-10.|
|Certificates of Pharmaceutical Product (Drug Export) Fees - AMENDED||Other Goods and Services (O)||Ministerial authority to enter into contract –Department of Health Act|
|Drug Establishment Licensing Fees - AMENDED||R||FAA|
|Drug Master File Fees - AMENDED||O||Ministerial authority to enter into contract –Department of Health Act|
|Drug Submission Evaluation Fees - AMENDED||R||FAA|
|Medical Device Licence Application Fees - AMENDED||R||FAA|
|Fees for Right to Sell a Licensed Medical Device - AMENDED||R||FAA|
|Medical Device Establishment Licensing Fees - AMENDED||R||FAA|
Additional information is available on the HPFB CRI website at http://www.healthcanada.gc.ca/hpfb_costrecovery